PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.31%
Revenue growth above 1.5x 3391.T's 1.12%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2.91%
Gross profit growth above 1.5x 3391.T's 1.32%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
7.71%
EBIT growth below 50% of 3391.T's 16.27%. Michael Burry would suspect deeper competitive or cost structure issues.
7.71%
Operating income growth under 50% of 3391.T's 15.49%. Michael Burry would be concerned about deeper cost or sales issues.
4.16%
Net income growth under 50% of 3391.T's 18.47%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.15%
EPS growth under 50% of 3391.T's 18.06%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.15%
Diluted EPS growth under 50% of 3391.T's 18.44%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 3391.T is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.03%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.83%
10Y revenue/share CAGR under 50% of 3391.T's 172.77%. Michael Burry would suspect a lasting competitive disadvantage.
51.99%
5Y revenue/share CAGR similar to 3391.T's 55.97%. Walter Schloss might see both companies benefiting from the same mid-term trends.
23.42%
3Y revenue/share CAGR above 1.5x 3391.T's 12.19%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.42%
Below 50% of 3391.T's 141.75%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
33.73%
Positive 5Y CAGR while 3391.T is negative. John Neff might view this as a strong mid-term relative advantage.
23.99%
Positive short-term CAGR while 3391.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
167.66%
10Y equity/share CAGR at 75-90% of 3391.T's 197.93%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
110.15%
5Y equity/share CAGR above 1.5x 3391.T's 56.42%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.73%
3Y equity/share CAGR above 1.5x 3391.T's 30.07%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.78%
3Y dividend/share CAGR of 77.78% while 3391.T is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
14.05%
AR growth well above 3391.T's 3.77%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.11%
Inventory is declining while 3391.T stands at 1.79%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.78%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
2.01%
Positive BV/share change while 3391.T is negative. John Neff sees a clear edge over a competitor losing equity.
-7.70%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.88%
We expand SG&A while 3391.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.